부산대학교 도서관

Neighbors, Margaret ; Cabanski, Christopher R ; Ramalingam, Thirumalai R ; Sheng, X Rebecca ; Tew, Gaik W ; Gu, Chunyan ; Jia, Guiquan ; Peng, Kun ; Ray, Jill M ; Ley, Brett ; Wolters, Paul J ; Collard, Harold R ; Arron, Joseph R

In The Lancet Respiratory Medicine August 2018 6(8):615-626

O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York, USA rhv@upenn.edu oreillye@mskcc.org.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Wainberg ZA; University of California Los Angeles, Los Angeles, California, USA.; Fisher GA; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Wolff RA; MD Anderson Gastrointestinal Cancer Center, Houston, Texas, USA.; Ko AH; Medicine (Division of Hematology/Oncology), University of California San Francisco, San Francisco, California, USA.; O'Hara MH; Medicine, Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Arnott J; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Moore JS; Abramson Cancer Center, Philadelphia, Pennsylvania, USA.; Peng B; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Hoos WA; 1440 Foundation, Scotts Valley, California, USA.; O'Donnell-Tormey J; Cancer Research Institute, New York, New York, USA.; Boffo S; Bristol Myers Squibb, Princeton, New Jersey, USA.; Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Kimmelman AC; NYU Langone Health Perlmutter Cancer Center, New York, New York, USA.; Amaravadi RK; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Vonderheide RH; Abramson Cancer Center, Philadelphia, Pennsylvania, USA rhv@upenn.edu oreillye@mskcc.org.; Parker Institute for Cancer Immunotherapy, Philadelphia, Pennsylvania, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Khalil DN; Memorial Sloan Kettering Cancer Center New York, NY United States.; Gomez R; Weill Cornell Medicine New York, NY United States.; Regev A; Weill Cornell Medicine New York, NY United States.; Samaan F; Weill Cornell Medicine New York, NY United States.; Marouf Y; Weill Cornell Medicine New York, NY United States.; Budhu S; Weill Cornell Medicine New York, New York United States.; Hirschhorn D; Weill Cornell Medicine New York, NY United States.; Schulze I; Memorial Sloan Kettering Cancer Center New York, NY United States.; Lavery JA; Memorial Sloan Kettering Cancer Center New York, New York United States.; Ceglia N; Memorial Sloan Kettering Cancer Center United States.; Freeman SS; Memorial Sloan Kettering Cancer Center New York, New York United States.; Maltez VI; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Garcia JM; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Suek N; Weill Cornell Medicine New York, NY United States.; Weng CH; Weill Cornell Medicine New York, NY United States.; Cabanski CR; Parker Institute for Cancer Immunotherapy San Francisco, CA United States.; Monette S; Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine New York, New York United States.; Romin Y; Memorial Sloan Kettering Cancer Center New York, NY United States.; Li Y; Bristol-Myers Squibb (United States) Cambridge, MA United States.; Chaligne R; Memorial Sloan Kettering Cancer Center New York, NY United States.; Yellin MJ; Celldex Therapeutics (United States) Hampton, New Jersey United States.; Keler T; Celldex Therapeutics, Inc. Hampton, NJ United States.; Maurer DM; Celldex Therapeutics (United States) Hampton, NJ United States.; Flamar AL; Weill Cornell Medicine New York, NY United States.; Morgado-Palacin L; Weill Cornell Medicine New York, NY United States.; Mangarin LM; Weill Cornell Medicine.; Harding JJ; Memorial Sloan Kettering Cancer Center New York, NY United States.; Park W; Memorial Sloan Kettering Cancer Center New York, NY United States.; Lyman JP; Lustgarten Foundation Uniondale, NY United States.; Maddock S; Parker Institute for Cancer Immunotherapy San Francisco, CA United States.; O'Hara MH; University of Pennsylvania Philadelphia, PA United States.; Abou-Alfa GK; Memorial Sloan Kettering Cancer Center New York, NY United States.; Vonderheide RH; University of Pennsylvania Philadelphia, Pennsylvania United States.; O'Reilly EM; Memorial Sloan Kettering Cancer Center New York, NY United States.; Germain RN; National Institute of Allergy and Infectious Diseases Bethesda, MD United States.; Wolchok JD; Weill Cornell Medicine New York, NY United States.; Merghoub T; Weill Cornell Medicine New York, NY United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Stewart MD; Friends of Cancer Research, Washington, District of Columbia, USA mstewart@focr.org.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Allen JD; Friends of Cancer Research, Washington, District of Columbia, USA.; Connolly JE; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Beneski BM; Allogene Therapeutics, South San Francisco, California, USA.; Dropulić B; Caring Cross, Gaithersburg, Maryland, USA.; Feldman SA; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, California, USA.; Fleisher LA; Rubrum Advising, Philadelphia, Pennsylvania, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Hanley PJ; Center for Cancer and Immunology Research, Children's National Hospital, Washington, District of Columbia, USA.; Department of Pediatrics, The George Washington University, Washington, District of Columbia, USA.; Hege K; Independent Advisor, Burlingame, California, USA.; Kekre N; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Fernandez Lynch H; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Mackall CL; Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, California, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

O'Hara, Mark H, MD; O'Reilly, Eileen M, MD; Varadhachary, Gauri, MD; Wolff, Robert A, MD; Wainberg, Zev A, MD; Ko, Andrew H, MD; Fisher, George, MD; Rahma, Osama, MD; Lyman, Jaclyn P, MSc; Cabanski, Christopher R, PhD; Mick, Rosemarie, MS; Gherardini, Pier Federico, PhD; Kitch, Lacey J, PhD; Xu, Jingying, PhD; Samuel, Theresa, MD; Karakunnel, Joyson, MD; Fairchild, Justin, MPH; Bucktrout, Samantha, PhD; LaVallee, Theresa M, PhD; Selinsky, Cheryl, PhD; Till, Jacob E, PhD; Carpenter, Erica L, PhD; Alanio, Cécile, PhD; Byrne, Katelyn T, PhD; Chen, Richard O, MD; Trifan, Ovid C, MD; Dugan, Ute, MD; Horak, Christine, PhD; Hubbard-Lucey, Vanessa M, PhD; Wherry, E John, PhD; Ibrahim, Ramy, MD; Vonderheide, Robert H, MD

The Lancet Oncology. 22(1):118-131

Weidhaas JB; UCLA David Geffen School of Medicine, Los Angeles, CA, USA. JWeidhaas@mednet.ucla.edu.; McGreevy KM; Department of Biostatistics, UCLA, Los Angeles, CA, USA.; Marco N; Department of Biostatistics, UCLA, Los Angeles, CA, USA.; Duke University, Durham, NC, USA.; Sundahl N; Department of Radiation Oncology, AZ Groeninge, Kortrijk, Belgium.; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spencer C; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Ost P; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Telesca D; Department of Biostatistics, UCLA, Los Angeles, CA, USA.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

Cabanski, Christopher R; Cavin, Keary; Bizon, Chris; Wilkerson, Matthew D; Parker, Matthew D; Parker, Joel S; Wilhelmsen, Kirk C; Perou, Charles M; Marron, JS; Hayes, D Neil

BMC Bioinformatics. 2012, Vol. 13 Issue 1, p221-230. 10p. 3 Diagrams.

Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Yang E; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Stewart MD; Friends of Cancer Research, Washington, District of Columbia, USA.; Allen JD; Friends of Cancer Research, Washington, District of Columbia, USA.; Connolly JE; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Greenberg PD; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Immunology, University of Washington, Seattle, Washington, USA.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, USA.; Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.; Division of Bone Marrow Transplant-Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Parker Institute for Cancer Immunotherapy at Stanford Medicine, Stanford Medicine, Stanford, California, USA.; June CH; Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Marson A; Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes, San Francisco, California, USA.; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy at Gladstone Institutes, Gladstone Institutes, San Francisco, California, USA.; Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, Massachusetts, USA aribas@mednet.ucla.edu mvmaus@mgh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ribas A; Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, USA aribas@mednet.ucla.edu mvmaus@mgh.harvard.edu.; Parker Institute for Cancer Immunotherapy at UCLA, University of California Los Angeles, Los Angeles, California, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Galsky MD; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Autio KA; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Wentzel K; The Angeles Clinic and Research Institute, Los Angeles, California.; Graff JN; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; VA Portland Health Care System, Portland, Oregon.; Friedlander TW; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Howes TR; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Shotts KM; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Spasic M; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Chen RO; Personalis, Inc., Menlo Park, California.; Lata J; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania.; Skolnik J; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania.; Keler T; Celldex Therapeutics, Inc., Hampton, New Jersey.; Yellin MJ; Celldex Therapeutics, Inc., Hampton, New Jersey.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Boffo S; Bristol Myers Squibb, New York, New York.; O'Donnell-Tormey J; Cancer Research Institute, New York, New York.; Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Bhardwaj N; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Subudhi SK; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Fong L; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Immunotherapy Integrated Research Center, Fred Hutchison Cancer Center, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alayli FA; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Okrah K; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Drakaki A; University of California, Los Angeles , Los Angeles, CA, USA.; Khalil DN; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Kummar S; Stanford University , Stanford, CA, USA.; Khan SA; Stanford University , Stanford, CA, USA.; Hodi FS; Dana-Farber Cancer Institute , Boston, MA, USA.; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute , Boston, MA, USA.; Oh DY; University of California, San Francisco , San Francisco, CA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Gautam S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Meier SL; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Stanford University , Stanford, CA, USA.; Amouzgar M; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Kageyama R; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Yang E; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Spasic M; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hollmann TJ; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Bristol Myers Squibb , New York, NY, USA.; Li Y; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Adamow M; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Wong P; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Moore JS; University of Pennsylvania , Philadelphia, PA, USA.; Velichko S; Natera Inc. , Austin, TX, USA.; Chen RO; Personalis Inc. , Fremont, CA, USA.; Kumar D; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Ibrahim R; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Dugan U; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Salvador L; Bristol Myers Squibb , New York, NY, USA.; Hubbard-Lucey VM; Cancer Research Institute , New York, NY, USA.; O'Donnell-Tormey J; Cancer Research Institute , New York, NY, USA.; Santulli-Marotto S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Fairchild J; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; James P. Allison Institute, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.; Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

Till JE; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; McDaniel L; Personalis, Inc., Menlo Park, CA, USA.; Chang C; Indiana University School of Medicine, Indianapolis, IN, USA.; Long Q; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Abbott C; Personalis, Inc., Menlo Park, CA, USA.; Chen RO; Personalis, Inc., Menlo Park, CA, USA.; Boyle SM; Personalis, Inc., Menlo Park, CA, USA.; Bhagwat N; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cannas S; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Sagreiya H; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Li W; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yee SS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Abdalla A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wang Z; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Yin M; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Ballinger D; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Wissel P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Eads J; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Karasic T; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Schneider C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; O'Dwyer P; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Teitelbaum U; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Reiss KA; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Rahma OE; Dana-Farber Cancer Institute, Boston, MA, USA.; Fisher GA; Stanford University, Stanford, CA, USA.; Ko AH; University of California, San Francisco, San Francisco, CA, USA.; Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA.; Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Carpenter EL; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. erical@upenn.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Wortman JR; Seres Therapeutics, Cambridge, Massachusetts.; Burton EM; Strategic Translational Research Initiative Development, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Alayli FA; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Loo CP; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Gautam S; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Damania A; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Portage Biotech, Westport, Connecticut.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Wong MC; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Weiner B; Seres Therapeutics, Cambridge, Massachusetts.; Hicks N; Seres Therapeutics, Cambridge, Massachusetts.; Aunins J; Seres Therapeutics, Cambridge, Massachusetts.; McChalicher C; Seres Therapeutics, Cambridge, Massachusetts.; Walsh E; Seres Therapeutics, Cambridge, Massachusetts.; Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, California.; Hamid O; Cutaneous Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sullivan RJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Grossmann KF; Providence Cancer Institute Franz Clinic, Portland, Oregon.; Ajami NJ; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Coherus BioSciences, Redwood City, California.; Henn MR; Seres Therapeutics, Cambridge, Massachusetts.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Cabanski, Christopher R; White, Nicole M; Dang, Ha X; Silva-Fisher, Jessica M; Rauck, Corinne E; Cicka, Danielle; Maher, Christopher A

RNA Biology. Jun2015, Vol. 12 Issue 6, p628-642. 15p.

Silva-Fisher JM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; Dang HX; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; The McDonnell Genome Institute, St. Louis, MO, USA.; White NM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; Strand MS; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Krasnick BA; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Rozycki EB; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Jeffers GGL; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Grossman JG; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Highkin MK; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Tang C; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Eteleeb A; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Mudd J; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Goedegebuure SP; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Luo J; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Mardis ER; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Wilson RK; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Ley TJ; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; Lockhart AC; Department of Medicine, University of Miami, Miami, FL, USA.; Fields RC; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.; Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.; Maher CA; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA. christophermaher@wustl.edu.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. christophermaher@wustl.edu.; The McDonnell Genome Institute, St. Louis, MO, USA. christophermaher@wustl.edu.; Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO, USA. christophermaher@wustl.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Lyman, Jaclyn P.; Cabanski, Christopher R; Maddock, Stephen; Wolff, Robert A.; Wainberg, Zev A.; Ko, Andrew H.; Rahma, Osama E.; Fisher, George A.; Gabriel, Peter Edward; Doucette, Abigail; Zheng-Lin, Binbin; Maloy, Molly A.; Dugan, Ute; Fairchild, Justin P.; Spasic, Marko; O'Donnell-Tormey, Jill; Vonderheide, Robert H.; O'Hara, Mark H.; O'Reilly, Eileen Mary

Journal of Clinical Oncology. 2/1/2023 Supplement 1, Vol. 41, p757-757. 1p.

White, Nicole M; Cabanski, Christopher R; Silva-Fisher, Jessica M; Dang, Ha X; Govindan, Ramaswamy; Maher, Christopher A

Genome Biology (Online Edition). August 13, 2014, Vol. 15

Padrón LJ; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. lpadron@parkerici.org.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; O'Hara MH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wolff RA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wainberg ZA; University of California, Los Angeles, Los Angeles, CA, USA.; Ko AH; University of California, San Francisco, San Francisco, CA, USA.; Fisher G; Stanford University, Stanford, CA, USA.; Rahma O; Dana-Farber Cancer Institute, Boston, MA, USA.; Lyman JP; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Yu JX; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Spasic M; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Xu J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Gherardini PF; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Mick R; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Alanio C; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Byrne KT; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Hollmann TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Moore JS; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Jones DD; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Tognetti M; Biognosys AG, Schlieren, Switzerland.; Chen RO; Personalis, Inc., Menlo Park, CA, USA.; Yang X; Apexigen, Inc., San Carlos, CA, USA.; Salvador L; Bristol Myers Squibb, New York, NY, USA.; Wherry EJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Dugan U; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; O'Donnell-Tormey J; Cancer Research Institute, New York, NY, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Hubbard-Lucey VM; Cancer Research Institute, New York, NY, USA.; Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Vonderheide RH; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Parker Institute of Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA. rhv@upenn.edu.; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. rhv@upenn.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Walter V; Yin X; Wilkerson MD; Cabanski CR; Zhao N; Du Y; Ang MK; Hayward MC; Salazar AH; Hoadley KA; Fritchie K; Sailey CJ; Weissler MC; Shockley WW; Zanation AM; Hackman T; Thorne LB; Funkhouser WD; Muldrew KL; Olshan AF; Randell SH; Wright FA; Shores CG; Hayes DN

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: PubMed not MEDLINE

Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA friedmac@mskcc.org.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Spencer C; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Panageas KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Ribas A; Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Tawbi H; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tsai K; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Postow M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Shoushtari A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Chapman P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Karakunnel J; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Gherardini P; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Hollmann TJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Chen RO; Personalis Inc, Menlo Park, California, USA.; Callahan M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Ibrahim R; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Wolchok J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Cheung D; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: cheung.dorothy@gene.com.; Fong A; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: fong.alice@gene.com.; Ding HT; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: dingh11@gene.com.; Cabanski CR; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: ccabanski@parkerici.org.; Wang J; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: wang.jianshuang@gene.com.; Chen Y; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: chen.yuan@gene.com.; Bush J; Covance Clinical Research Unit, Ltd, Springfield House, Hyde Street, Leeds, LS2 9LH UK. Electronic address: jim.bush@covance.com.; Harris JM; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: jharrisofsf@gmail.com.; Pan L; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. Electronic address: pan.lin@gene.co.

Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-9629 (Electronic) Linking ISSN: 10945539 NLM ISO Abbreviation: Pulm Pharmacol Ther Subsets: MEDLINE